List of Tables
Table 1. Malaria Vaccines Market Trends
Table 2. Malaria Vaccines Market Drivers & Opportunity
Table 3. Malaria Vaccines Market Challenges
Table 4. Malaria Vaccines Market Restraints
Table 5. Global Malaria Vaccines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Malaria Vaccines Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Malaria Vaccines Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Malaria Vaccines Product Type
Table 9. Key Companies Time to Begin Mass Production of Malaria Vaccines
Table 10. Global Malaria Vaccines Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Malaria Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Malaria Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Malaria Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Malaria Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Malaria Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Malaria Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Malaria Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Malaria Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Malaria Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Malaria Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Malaria Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Malaria Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Malaria Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Malaria Vaccines Sales Value by Region (2019-2024) & (%)
Table 27. Global Malaria Vaccines Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Malaria Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Malaria Vaccines Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Malaria Vaccines Sales Value, (2025-2030) & (US$ Million)
Table 31. GlaxoSmithKline Plc Basic Information List
Table 32. GlaxoSmithKline Plc Description and Business Overview
Table 33. GlaxoSmithKline Plc Malaria Vaccines Products, Services and Solutions
Table 34. Revenue (US$ Million) in Malaria Vaccines Business of GlaxoSmithKline Plc (2019-2024)
Table 35. GlaxoSmithKline Plc Recent Developments
Table 36. Sanaria Inc Basic Information List
Table 37. Sanaria Inc Description and Business Overview
Table 38. Sanaria Inc Malaria Vaccines Products, Services and Solutions
Table 39. Revenue (US$ Million) in Malaria Vaccines Business of Sanaria Inc (2019-2024)
Table 40. Sanaria Inc Recent Developments
Table 41. Nobelpharma Co Basic Information List
Table 42. Nobelpharma Co Description and Business Overview
Table 43. Nobelpharma Co Malaria Vaccines Products, Services and Solutions
Table 44. Revenue (US$ Million) in Malaria Vaccines Business of Nobelpharma Co (2019-2024)
Table 45. Nobelpharma Co Recent Developments
Table 46. Sumaya Biotech Basic Information List
Table 47. Sumaya Biotech Description and Business Overview
Table 48. Sumaya Biotech Malaria Vaccines Products, Services and Solutions
Table 49. Revenue (US$ Million) in Malaria Vaccines Business of Sumaya Biotech (2019-2024)
Table 50. Sumaya Biotech Recent Developments
Table 51. GenVec Basic Information List
Table 52. GenVec Description and Business Overview
Table 53. GenVec Malaria Vaccines Products, Services and Solutions
Table 54. Revenue (US$ Million) in Malaria Vaccines Business of GenVec (2019-2024)
Table 55. GenVec Recent Developments
Table 56. Actiza Pharmaceutical Private Limited Basic Information List
Table 57. Actiza Pharmaceutical Private Limited Description and Business Overview
Table 58. Actiza Pharmaceutical Private Limited Malaria Vaccines Products, Services and Solutions
Table 59. Revenue (US$ Million) in Malaria Vaccines Business of Actiza Pharmaceutical Private Limited (2019-2024)
Table 60. Actiza Pharmaceutical Private Limited Recent Developments
Table 61. AdvaCare Pharma Basic Information List
Table 62. AdvaCare Pharma Description and Business Overview
Table 63. AdvaCare Pharma Malaria Vaccines Products, Services and Solutions
Table 64. Revenue (US$ Million) in Malaria Vaccines Business of AdvaCare Pharma (2019-2024)
Table 65. AdvaCare Pharma Recent Developments
Table 66. Ipca Laboratories Ltd Basic Information List
Table 67. Ipca Laboratories Ltd Description and Business Overview
Table 68. Ipca Laboratories Ltd Malaria Vaccines Products, Services and Solutions
Table 69. Revenue (US$ Million) in Malaria Vaccines Business of Ipca Laboratories Ltd (2019-2024)
Table 70. Ipca Laboratories Ltd Recent Developments
Table 71. Bliss GVS Pharma Ltd Basic Information List
Table 72. Bliss GVS Pharma Ltd Description and Business Overview
Table 73. Bliss GVS Pharma Ltd Malaria Vaccines Products, Services and Solutions
Table 74. Revenue (US$ Million) in Malaria Vaccines Business of Bliss GVS Pharma Ltd (2019-2024)
Table 75. Bliss GVS Pharma Ltd Recent Developments
Table 76. GeoVax Basic Information List
Table 77. GeoVax Description and Business Overview
Table 78. GeoVax Malaria Vaccines Products, Services and Solutions
Table 79. Revenue (US$ Million) in Malaria Vaccines Business of GeoVax (2019-2024)
Table 80. GeoVax Recent Developments
Table 81. Pfizer Inc Basic Information List
Table 82. Pfizer Inc Description and Business Overview
Table 83. Pfizer Inc Malaria Vaccines Products, Services and Solutions
Table 84. Revenue (US$ Million) in Malaria Vaccines Business of Pfizer Inc (2019-2024)
Table 85. Pfizer Inc Recent Developments
Table 86. VLP Therapeutics Basic Information List
Table 87. VLP Therapeutics Description and Business Overview
Table 88. VLP Therapeutics Malaria Vaccines Products, Services and Solutions
Table 89. Revenue (US$ Million) in Malaria Vaccines Business of VLP Therapeutics (2019-2024)
Table 90. VLP Therapeutics Recent Developments
Table 91. OSIVAX Basic Information List
Table 92. OSIVAX Description and Business Overview
Table 93. OSIVAX Malaria Vaccines Products, Services and Solutions
Table 94. Revenue (US$ Million) in Malaria Vaccines Business of OSIVAX (2019-2024)
Table 95. OSIVAX Recent Developments
Table 96. AJANTA PHARMA Basic Information List
Table 97. AJANTA PHARMA Description and Business Overview
Table 98. AJANTA PHARMA Malaria Vaccines Products, Services and Solutions
Table 99. Revenue (US$ Million) in Malaria Vaccines Business of AJANTA PHARMA (2019-2024)
Table 100. AJANTA PHARMA Recent Developments
Table 101. Strides Pharma Science Limited Basic Information List
Table 102. Strides Pharma Science Limited Description and Business Overview
Table 103. Strides Pharma Science Limited Malaria Vaccines Products, Services and Solutions
Table 104. Revenue (US$ Million) in Malaria Vaccines Business of Strides Pharma Science Limited (2019-2024)
Table 105. Strides Pharma Science Limited Recent Developments
Table 106. Mylan N.V. Basic Information List
Table 107. Mylan N.V. Description and Business Overview
Table 108. Mylan N.V. Malaria Vaccines Products, Services and Solutions
Table 109. Revenue (US$ Million) in Malaria Vaccines Business of Mylan N.V. (2019-2024)
Table 110. Mylan N.V. Recent Developments
Table 111. Zydus Cadila Basic Information List
Table 112. Zydus Cadila Description and Business Overview
Table 113. Zydus Cadila Malaria Vaccines Products, Services and Solutions
Table 114. Revenue (US$ Million) in Malaria Vaccines Business of Zydus Cadila (2019-2024)
Table 115. Zydus Cadila Recent Developments
Table 116. Cipla Inc Basic Information List
Table 117. Cipla Inc Description and Business Overview
Table 118. Cipla Inc Malaria Vaccines Products, Services and Solutions
Table 119. Revenue (US$ Million) in Malaria Vaccines Business of Cipla Inc (2019-2024)
Table 120. Cipla Inc Recent Developments
Table 121. Sun Pharmaceutical Industries Ltd Basic Information List
Table 122. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 123. Sun Pharmaceutical Industries Ltd Malaria Vaccines Products, Services and Solutions
Table 124. Revenue (US$ Million) in Malaria Vaccines Business of Sun Pharmaceutical Industries Ltd (2019-2024)
Table 125. Sun Pharmaceutical Industries Ltd Recent Developments
Table 126. Sanofi Basic Information List
Table 127. Sanofi Description and Business Overview
Table 128. Sanofi Malaria Vaccines Products, Services and Solutions
Table 129. Revenue (US$ Million) in Malaria Vaccines Business of Sanofi (2019-2024)
Table 130. Sanofi Recent Developments
Table 131. Hikma Pharmaceuticals PLC Basic Information List
Table 132. Hikma Pharmaceuticals PLC Description and Business Overview
Table 133. Hikma Pharmaceuticals PLC Malaria Vaccines Products, Services and Solutions
Table 134. Revenue (US$ Million) in Malaria Vaccines Business of Hikma Pharmaceuticals PLC (2019-2024)
Table 135. Hikma Pharmaceuticals PLC Recent Developments
Table 136. Amneal Pharmaceuticals LLC Basic Information List
Table 137. Amneal Pharmaceuticals LLC Description and Business Overview
Table 138. Amneal Pharmaceuticals LLC Malaria Vaccines Products, Services and Solutions
Table 139. Revenue (US$ Million) in Malaria Vaccines Business of Amneal Pharmaceuticals LLC (2019-2024)
Table 140. Amneal Pharmaceuticals LLC Recent Developments
Table 141. Taj Pharmaceuticals Limited Basic Information List
Table 142. Taj Pharmaceuticals Limited Description and Business Overview
Table 143. Taj Pharmaceuticals Limited Malaria Vaccines Products, Services and Solutions
Table 144. Revenue (US$ Million) in Malaria Vaccines Business of Taj Pharmaceuticals Limited (2019-2024)
Table 145. Taj Pharmaceuticals Limited Recent Developments
Table 146. Lupin Basic Information List
Table 147. Lupin Description and Business Overview
Table 148. Lupin Malaria Vaccines Products, Services and Solutions
Table 149. Revenue (US$ Million) in Malaria Vaccines Business of Lupin (2019-2024)
Table 150. Lupin Recent Developments
Table 151. Novartis AG Basic Information List
Table 152. Novartis AG Description and Business Overview
Table 153. Novartis AG Malaria Vaccines Products, Services and Solutions
Table 154. Revenue (US$ Million) in Malaria Vaccines Business of Novartis AG (2019-2024)
Table 155. Novartis AG Recent Developments
Table 156. CellFree Sciences Basic Information List
Table 157. CellFree Sciences Description and Business Overview
Table 158. CellFree Sciences Malaria Vaccines Products, Services and Solutions
Table 159. Revenue (US$ Million) in Malaria Vaccines Business of CellFree Sciences (2019-2024)
Table 160. CellFree Sciences Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Malaria Vaccines Downstream Customers
Table 164. Malaria Vaccines Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 168. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Malaria Vaccines Product Picture
Figure 2. Global Malaria Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Malaria Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Malaria Vaccines Report Years Considered
Figure 5. Global Malaria Vaccines Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Malaria Vaccines Revenue in 2023
Figure 7. Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Pre-Erythrocytic Vaccine Picture
Figure 9. Erythrocytic Vaccine Picture
Figure 10. Multi-antigen Vaccine Picture
Figure 11. Global Malaria Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Malaria Vaccines Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Clinics
Figure 15. Product Picture of Community Centers
Figure 16. Global Malaria Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Malaria Vaccines Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Malaria Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Malaria Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Malaria Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Malaria Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Malaria Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Malaria Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Malaria Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Malaria Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Malaria Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Malaria Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Malaria Vaccines Sales Value (%), (2019-2030)
Figure 29. United States Malaria Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Malaria Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Malaria Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Malaria Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Malaria Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Malaria Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 35. China Malaria Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Malaria Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 37. China Malaria Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Malaria Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Malaria Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Malaria Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Malaria Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Malaria Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Malaria Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Malaria Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Malaria Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Malaria Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 47. India Malaria Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Malaria Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 49. India Malaria Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 50. Malaria Vaccines Industrial Chain
Figure 51. Malaria Vaccines Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
